It acts on receptors in your stomach to tell you you are full
Your provider monitors progress through follow-up appointments, adjusts dosing based on your response, and catches complications early
Additionally, it has been shown to enhance symptoms, improve physical fitness, and lower inflammation and body weight in patients with obesity and heart failure with preserved ejection fraction (Kosiborod et al., 2023)
It modulates inflammatory and apoptotic markers, enhances antioxidant defenses, and suppresses JNK/p-PERK and Caspase-12 signaling
Contact: Emily Passer [email protected] Data & methodology Weight loss and engagement: January 2026 analysis of 14,203 Noom GLP-1 Rx Program members who started a GLP-1 Rx plan between December 2024 and February 2025 and logged weight during a measurement week (4, 8, 16, 40 weeks)
the UK regulatory gap